BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang LM, Zhang J, Zhang Y, Fei C, Wang L, Yi ZW, Zhang ZQ. Interleukin-18 promotes fibroblast senescence in pulmonary fibrosis through down-regulating Klotho expression. Biomed Pharmacother 2019;113:108756. [PMID: 30870716 DOI: 10.1016/j.biopha.2019.108756] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma H, Liu S, Li S, Xia Y. Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis. Front Pharmacol 2022;13:918771. [PMID: 35721111 DOI: 10.3389/fphar.2022.918771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang Z, Gao J, Xu C. Tackling cellular senescence by targeting miRNAs. Biogerontology 2022. [PMID: 35727469 DOI: 10.1007/s10522-022-09972-z] [Reference Citation Analysis]
3 Colunga Biancatelli RML, Solopov PA, Catravas JD. The Inflammasome NLR Family Pyrin Domain-Containing Protein 3 (NLRP3) as a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis. Am J Pathol 2022;192:837-46. [PMID: 35351468 DOI: 10.1016/j.ajpath.2022.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Artlett CM. The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. Biomolecules 2022;12:634. [DOI: 10.3390/biom12050634] [Reference Citation Analysis]
5 Tai G, Yu Q, Li J, Wei W, Ji X, Zheng R, Li X, Wei L, Xu M. NLRP3 inflammasome links vascular senescence to diabetic vascular lesions. Pharmacological Research 2022;178:106143. [DOI: 10.1016/j.phrs.2022.106143] [Reference Citation Analysis]
6 Yang J, Cai M, Wan J, Wang L, Luo J, Li X, Gong W, He Y, Chen J. Effluent decoy receptor 2 as a novel biomarker of peritoneal fibrosis in peritoneal dialysis patients. Perit Dial Int 2022;:8968608211067866. [PMID: 35176936 DOI: 10.1177/08968608211067866] [Reference Citation Analysis]
7 Scott TE, Qin CX, Drummond GR, Hobbs AJ, Kemp-Harper BK. Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019. Hypertension 2021;78:1168-84. [PMID: 34565184 DOI: 10.1161/HYPERTENSIONAHA.120.14525] [Reference Citation Analysis]
8 Sakai T, Takagaki H, Yamagiwa N, Ui M, Hatta S, Imai J. Effects of the Cytoplasm and Mitochondrial Specific Hydroxyl Radical Scavengers TA293 and mitoTA293 in Bleomycin-Induced Pulmonary Fibrosis Model Mice. Antioxidants (Basel) 2021;10:1398. [PMID: 34573030 DOI: 10.3390/antiox10091398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Nakanishi Y, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Nakashima T, Miyamoto S, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis. PLoS One 2021;16:e0252594. [PMID: 34086758 DOI: 10.1371/journal.pone.0252594] [Reference Citation Analysis]
10 Su L, Dong Y, Wang Y, Wang Y, Guan B, Lu Y, Wu J, Wang X, Li D, Meng A, Fan F. Potential role of senescent macrophages in radiation-induced pulmonary fibrosis. Cell Death Dis 2021;12:527. [PMID: 34023858 DOI: 10.1038/s41419-021-03811-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cominal JG, Cacemiro MDC, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, de Figueiredo-Pontes LL, Oliveira MC, Malmegrim KCR, de Castro FA. Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms. Front Oncol 2021;11:665037. [PMID: 34084749 DOI: 10.3389/fonc.2021.665037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Stojanović SD, Fiedler J, Bauersachs J, Thum T, Sedding DG. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. Eur Heart J 2020;41:2983-96. [PMID: 31898722 DOI: 10.1093/eurheartj/ehz919] [Cited by in Crossref: 36] [Cited by in F6Publishing: 55] [Article Influence: 36.0] [Reference Citation Analysis]
13 She YX, Yu QY, Tang XX. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov 2021;7:52. [PMID: 33723241 DOI: 10.1038/s41420-021-00437-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
14 Barnes PJ, Anderson GP, Fagerås M, Belvisi MG. Chronic lung diseases: prospects for regeneration and repair. Eur Respir Rev 2021;30:200213. [PMID: 33408088 DOI: 10.1183/16000617.0213-2020] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Wu B, Tang L, Kapoor M. Fibroblasts and their responses to chronic injury in pulmonary fibrosis. Semin Arthritis Rheum 2021;51:310-7. [PMID: 33440304 DOI: 10.1016/j.semarthrit.2020.12.003] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Wu Q, Zhang KJ, Jiang SM, Fu L, Shi Y, Tan RB, Cui J, Zhou Y. p53: A Key Protein That Regulates Pulmonary Fibrosis. Oxid Med Cell Longev 2020;2020:6635794. [PMID: 33312337 DOI: 10.1155/2020/6635794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lin Y, Xu Z. Fibroblast Senescence in Idiopathic Pulmonary Fibrosis. Front Cell Dev Biol 2020;8:593283. [PMID: 33324646 DOI: 10.3389/fcell.2020.593283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
18 Miao H, Wu XQ, Zhang DD, Wang YN, Guo Y, Li P, Xiong Q, Zhao YY. Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues. Pharmacol Res 2021;163:105316. [PMID: 33248198 DOI: 10.1016/j.phrs.2020.105316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yang S, Cui W, Wang M, Xing L, Wang Y, Zhu P, Qu Q, Tang Q. Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation. Evid Based Complement Alternat Med 2020;2020:7483278. [PMID: 32963571 DOI: 10.1155/2020/7483278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Corrêa HL, Neves RVP, Deus LA, Souza MK, Haro AS, Costa F, Silva VL, Santos CAR, Moraes MR, Simões HG, Navalta JW, Prestes J, Rosa TS. Blood Flow Restriction Training Blunts Chronic Kidney Disease Progression in Humans. Medicine & Science in Sports & Exercise 2021;53:249-57. [DOI: 10.1249/mss.0000000000002465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
21 Milczarek M. The Premature Senescence in Breast Cancer Treatment Strategy. Cancers (Basel) 2020;12:E1815. [PMID: 32640718 DOI: 10.3390/cancers12071815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
22 Huang Q, Chen Y, Shen S, Wang Y, Liu L, Wu S, Xu W, Zhao W, Lin M, Wu J. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis. Aging (Albany NY) 2020;12:5812-31. [PMID: 32244228 DOI: 10.18632/aging.102978] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Liu RM, Liu G. Cell senescence and fibrotic lung diseases. Exp Gerontol 2020;132:110836. [PMID: 31958492 DOI: 10.1016/j.exger.2020.110836] [Cited by in Crossref: 22] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
24 Li X, Li Z, Li B, Zhu X, Lai X. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Life Sci 2019;234:116773. [PMID: 31422095 DOI: 10.1016/j.lfs.2019.116773] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
25 Caporarello N, Meridew JA, Jones DL, Tan Q, Haak AJ, Choi KM, Manlove LJ, Prakash YS, Tschumperlin DJ, Ligresti G. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state. Thorax 2019;74:749-60. [PMID: 31182654 DOI: 10.1136/thoraxjnl-2019-213064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]